Ekso Bionics (EKSO) to Announce Quarterly Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) will likely be announcing its Q1 2025 earnings results before the market opens on Monday, May 5th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $4.62 million for the quarter.

Ekso Bionics (NASDAQ:EKSO) last announced its quarterly earnings data on Monday, March 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.07). The company had revenue of $5.09 million during the quarter, compared to analyst estimates of $5.05 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Trading Up 2.8 %

Shares of Ekso Bionics stock opened at $0.44 on Monday. The company’s fifty day simple moving average is $0.44 and its 200-day simple moving average is $0.63. The company has a market cap of $12.83 million, a price-to-earnings ratio of -0.68 and a beta of 1.33. The company has a current ratio of 2.81, a quick ratio of 2.14 and a debt-to-equity ratio of 0.28. Ekso Bionics has a 1 year low of $0.34 and a 1 year high of $1.53.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on EKSO shares. HC Wainwright restated a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research note on Tuesday, March 4th. StockNews.com initiated coverage on Ekso Bionics in a research report on Monday. They issued a “hold” rating for the company. Finally, Lake Street Capital reduced their target price on Ekso Bionics from $2.00 to $1.00 and set a “buy” rating for the company in a research report on Tuesday, March 4th.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.